Daptomycin and rifampin for the treatment of methicillin-resistant staphylococcus aureus septic pulmonary emboli in the absence of endocarditis

Microbial Drug Resistance

Volumn 16, Issue 3, 2010, Pages 241-244

  Gomez, Eric O ^a   Jafary, Ahmar ^a   Dever, Lisa L ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; DAPTOMYCIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; DRUG EFFICACY; DRUG WITHDRAWAL; FATALITY; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; LUNG EMBOLISM; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; SOFT TISSUE INFECTION; TREATMENT FAILURE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PULMONARY EMBOLISM; RIFAMPIN; SEPSIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 77956569200     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0001     Document Type: Article

References (20)

1. Alder, J., R.D. Arbeit, B. Eisenstein, F. Tally, H. Haine, and J. Silverman. 2004. Pulmonary epithelial lining fluid (ELF) as a privileged site: daptomycin in pulmonary infections [abstract 60.005]. Presented at the 11th International Congress on Infectious Diseases, Cancun, Mexico.
2. Cosgrove, S.E., G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36:53-59. (Pubitemid 36099097)
3. Cunha, B.A., N. Hamid, H. Kessler, and S. Parchuri. 2005. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Heart Lung 34:442-447.
4. Fowler, V.G., Jr., H.W. Boucher, G.R. Corey, E. Abrutyn, A.W. Karchmer, M.E. Rupp, D.P. Levine, H.F. Chambers, F.P. Tally, G.A. Vigliani, C.H. Cabell, A.S. Link, I. De-Meyer, S.G. Filler, M. Zervos, P. Cook, J. Parsonnet, J.M. Bernstein, C.S. Price, G.N. Forrest, G. Fatkenheuer, M. Gareca, S.J. Rehm, H.R. Brodt, A. Tice, and S.E. Cosgrove. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653-665.
5. Fuchs, P.C., A.L. Barry, and S.D. Brown. 2002. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 49:467-470.
6. Gonzalez, B.E., K.G. Hulten, M.K. Dishop, L.B. Lamberth, W.A. Hammerman, E.O. Mason, Jr., and S.L. Kaplan. 2005. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41:583-590.
7. Hayden, M.K., K. Rezai, R.A. Hayes, K. Lolans, J.P. Quinn, and R.A. Weinstein. 2005. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus au-reus. J. Clin. Microbiol. 43:5285-5287.
8. Koplowicz, Y.B., B.S. Schwartz, and B.J. Guglielmo. 2009. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. Clin. Infect. Dis. 49:1286-1287.
9. Lin, M.Y., K. Rezai, and D.N. Schwartz. 2008. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 46:1553-1555.
10. Liu, C.Y., J.L. Wang, Y.T. Huang, and P.R. Hsueh. 2008. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 32:544-545.
11. Lodise, T.P., J. Graves, A. Evans, E. Graffunder, M. Hel-mecke, B.M. Lomaestro, and K. Stellrecht. 2008. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents Chemother. 52:3315-3320.
12. MacMillan, J.C., S.H. Milstein, and P.C. Samson. 1978. Clinical spectrum of septic pulmonary embolism and infarction. J. Thorac. Cardiovasc. Surg. 75:670-679.
13. Moise, P.A., D. North, J.N. Steenbergen, and G. Sakoulas. 2009. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect. Dis. 9:617-624.
14. O'Donnell, A.E., and L.S. Pappas. 1988. Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest 94:251-253.
15. Pertel, P.E., P. Bernardo, C. Fogarty, P. Matthews, R. Northland, M. Benvenuto, G.M. Thorne, S.A. Luperchio, R.D. Arbeit, and J. Alder. 2008. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. Clin. Infect. Dis. 46:1142-1151.
16. Rehm, S.J., H. Boucher, D. Levine, M. Campion, B.I. Eisenstein, G.A. Vigliani, G.R. Corey, and E. Abrutyn. 2008. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. J. Antimicrob. Chemother. 62:1413-1421.
17. Sakoulas, G., P.A. Moise-Broder, J. Schentag, A. Forrest, R.C. Moellering, Jr., and G.M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vanco-mycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
18. Silverman, J.A., L.I. Mortin, A.D. Vanpraagh, T. Li, and J. Alder. 2005. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J. Infect. Dis. 191:2149-2152.
19. Soriano, A., F. Marco, J.A. Martinez, E. Pisos, M. Almela, V.P. Dimova, D. Alamo, M. Ortega, J. Lopez, and J. Mensa. 2008. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphy-lococcus aureus bacteremia. Clin. Infect. Dis. 46:193-200. (Pubitemid 351269157)
20. Steenbergen, J.N., J.F. Mohr, and G.M. Thorne. 2009. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J. Antimicrob. Chemother. 64:1130-1138.